Table 3 POMS2 TMD scores and subscores difference before and after U-K test, and changes from baseline.

From: Lactococcus cremoris YRC3780 improves subjective stress response in the Uchida-Kraepelin test: a randomized, double-blind, placebo-controlled study

 

Placebo

YRC3780

Baseline

Week 8

Baseline

Week 8

TMD score difference before and after U-K test

4.0 ± 4.4

2.9 ± 7.1

3.6 ± 3.4

–0.8 ± 5.5 *

Change in score from baseline (points)

–1.2 ± 6.4

–4.4 ± 6.2 *

Percentage change from baseline (%)

–22.8 ± 379.0

–167.6 ± 204.4*

AH score difference before and after U-K test

2.3 ± 5.3

0.3 ± 5.3

1.6 ± 5.2

–1.9 ± 5.1 *

Change in score from baseline (points)

–2.1 ± 5.6

–3.6 ± 6.9 *

Percentage change from baseline (%)

–28.5 ± 214.6

–78.2 ± 190.9

CB score difference before and after U-K test

3.5 ± 5.5

3.4 ± 7.7

3.8 ± 4.7

–0.3 ± 6.0 *

Change in score from baseline (points)

–0.1 ± 7.5

–4.1 ± 7.2 *

Percentage change from baseline (%)

2.0 ± 290.0

–64.6 ± 179.2

DD score difference before and after U-K test

3.1 ± 6.3

2.0 ± 6.6

1.9 ± 4.5

–2.0 ± 3.9 *

Change in score from baseline (points)

–1.0 ± 7.7

–3.9 ± 6.5 *

Percentage change from baseline (%)

38.1 ± 256.9

–117.5 ± 224.9 *

FI score difference before and after U-K test

6.0 ± 7.3

2.9 ± 7.8

5.6 ± 5.8

–0.2 ± 8.0 *

Change in score from baseline (points)

–3.1 ± 7.9

–5.9 ± 9.3 *

Percentage change from baseline (%)

–54.0 ± 129.4

–128.9 ± 282.0

TA score difference before and after U-K test

3.7 ± 6.0

2.0 ± 7.9

3.0 ± 5.8

–1.3 ± 7.2 *

Change in score from baseline (points)

–1.6 ± 7.3

–4.2 ± 7.1 *

Percentage change from baseline (%)

4.0 ± 387.8

–130.8 ± 259.4 *

VA score difference before and after U-K test

–1.7 ± 6.2

–3.4 ± 6.6

–2.0 ± 5.7

–2.7 ± 5.8

Change in score from baseline (points)

–1.7 ± 9.1

–0.7 ± 7.1

Percentage change from baseline (%)

–103.5 ± 347.1

–80.1 ± 327.1

F score difference before and after U-K test

–3.8 ± 7.5

–4.7 ± 6.3

–4.4 ± 7.6

–3.8 ± 5.4

Change in score from baseline (points)

–0.8 ± 8.8

0.6 ± 8.8

Percentage change from baseline (%)

–39.4 ± 186.1

–11.7 ± 153.0

  1. Data are shown as means ± SD (Placebo, n = 53, YRC3780, n = 54).
  2. Significant differences (*p < 0.05, ANCOVA with each initial value as a covariate) between the placebo and YRC3780 groups are indicated.
  3. TA, Tension–Anxiety, DD, Depression–Dejection, AH, Anger–Hostility, CB, Confusion–Bewilderment, AH, Anger–Hostility, VA, Vigor–Activity FI, Fatigue–Inertia, F, Friendliness.